4//SEC Filing
Tamboli Ajim 4
Accession 0001209191-23-000951
CIK 0001826457other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:30 PM ET
Size
5.5 KB
Accession
0001209191-23-000951
Insider Transaction Report
Form 4
Tamboli Ajim
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03+129,850→ 129,850 totalExercise: $7.78Exp: 2033-01-02→ Common Stock (129,850 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001855684
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:30 PM ET
- Size
- 5.5 KB